These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5289024)

  • 1. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor.
    Levin AS; Spitler LE; Stites DP; Fudenberg HH
    Proc Natl Acad Sci U S A; 1970 Oct; 67(2):821-8. PubMed ID: 5289024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer factor therapy in immuno-deficiencies.
    Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
    Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses of transfer factor.
    Basten A; Croft S; Kenny DF; Nelson DS
    Vox Sang; 1975; 28(4):257-77. PubMed ID: 804764
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of the transfer factor].
    Mutz I; Humphrey GB
    Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of transfer factor therapy on mixed lymphocyte culture reactivity.
    Dupont B; Ballow M; Hansen JA; Quick C; Yunis EJ; Good RA
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):867-71. PubMed ID: 4274562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor.
    Ballow M; Dupont B; Good RA
    J Pediatr; 1973 Nov; 83(5):772-80. PubMed ID: 4742570
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic and clinical implications of transfer factor.
    Mutz I; Lankford J; Humphrey GB
    South Med J; 1974 Jul; 67(7):837-40. PubMed ID: 4599982
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer factor.
    Good RA
    Cell Immunol; 1972 Apr; 3(4):i-iv. PubMed ID: 4554090
    [No Abstract]   [Full Text] [Related]  

  • 13. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor.
    Sellars WA; South MA
    Am J Dis Child; 1975 May; 129(5):622-7. PubMed ID: 806224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfer factor and its therapeutic use].
    Rosenthal M
    Schweiz Med Wochenschr; 1974 Oct; 104(43):1501-6. PubMed ID: 4549135
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immunity.
    Valentine FT; Lawrence HS
    Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
    [No Abstract]   [Full Text] [Related]  

  • 16. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosette-forming cells, immunologic deficiency diseases and transfer factor.
    Wybran J; Levin AS; Spitler LE; Fudenberg HH
    N Engl J Med; 1973 Apr; 288(14):710-3. PubMed ID: 4540063
    [No Abstract]   [Full Text] [Related]  

  • 20. Phytohemagglutinin as a skin test for the evaluation of cellular immune competence in man.
    Blaese RM; Weiden P; Oppenheim JJ; Waldmann TA
    J Lab Clin Med; 1973 Apr; 81(4):538-48. PubMed ID: 4696186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.